Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZNTL
DateTimeSourceHeadlineSymbolCompany
15/03/202515:25GlobeNewswire Inc.Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s CancerNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/03/202522:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/03/202513:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s CancerNASDAQ:ZNTLZentalis Pharmaceuticals Inc
24/02/202521:05GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
12/02/202522:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
12/02/202501:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/02/202523:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/02/202523:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
05/02/202523:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/02/202521:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/02/202500:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/02/202500:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/02/202522:42GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/01/202514:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/01/202512:00GlobeNewswire Inc.Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian CancerNASDAQ:ZNTLZentalis Pharmaceuticals Inc
28/01/202521:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
28/01/202521:05GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib DevelopmentNASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/01/202512:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical StudiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/01/202522:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
02/01/202521:53GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
19/12/202421:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
12/12/202412:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Key Management AppointmentsNASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/12/202400:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
02/12/202421:35GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/11/202422:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/11/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/11/202413:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of AzenosertibNASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/11/202423:04GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
04/10/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
17/09/202401:38PR Newswire (US)Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law FirmNASDAQ:ZNTLZentalis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZNTL